Of the almost 60 previously described KCNB1 channelopathy patients, 85% had developed epilepsy and all had developmental delays, with varying degrees of severity (Bar et al., 2020; de Kovel et al., 2017; Bar et al., 2020; Xiong et al., 2021). This evidence concerns the gene KCNB1 and epilepsy.